The Oasis Health Journal · Submitted July 12, 2026 · 11:18 AM ET

Humanity built a whole cuisine, a whole export economy, and roughly nine hundred food blogs around olive oil. The olive leaf, meanwhile, gets raked into a pile and left out with the yard waste. This is a little awkward, because the leaf is where the tree keeps most of the interesting chemistry. Olive leaves run somewhere between 1 and 14 percent oleuropein, the bitter polyphenol that keeps turning up in blood-pressure research. Olive oil runs about 0.005 to 0.12 percent. We have, in other words, been bottling the garnish and composting the medicine.

Oleuropein is why olive leaf tea has been a folk remedy around the Mediterranean for centuries, long before anyone could spell 'polyphenol.' The tradition was confident. The evidence took its time. In 2025 it finally got its largest hearing.

621 people, twelve weeks, and a cuff that never clocked out

The trial, published in the Journal of Hypertension, enrolled 621 adults who were already being treated for high blood pressure. Half added an olive leaf extract to their routine, half added a matching placebo, and nobody, patients or doctors, knew who got which. Rather than trust one nervous reading in a clinic, everyone wore a 24-hour ambulatory monitor, the kind that squeezes your arm every so often through dinner, traffic, and sleep. It is annoying, and it is also much harder to fool than a single measurement.

After twelve weeks, the olive leaf group's 24-hour systolic pressure fell 6.4 mmHg from where it started (95 percent confidence interval, about 10 down to 2). Their 'blood pressure load,' the share of readings that ran high across the whole day, dropped from roughly 54 percent to 42 percent. Triglycerides, blood sugar, C-reactive protein (an inflammation marker), and body weight all drifted in the helpful direction, and there were no serious side effects. Now the honest asterisk: measured head-to-head against the placebo group instead of against its own starting point, the extra benefit shrank to about 1.5 mmHg, and that particular comparison was not statistically airtight. The leaf helped. It did not stage a coup. It is also worth knowing that one of the study's listed affiliations is a supplement maker, which is common in this field and a good reason to read the confidence intervals rather than the press release.

Why a leaf would lean on your arteries at all

The leading explanation is nitric oxide, the small molecule that tells the muscle in your vessel walls to unclench. Oleuropein appears to coax more of it into circulation, which lets stiff arteries relax and drops the pressure inside them. Researchers have also watched it act like a mild antioxidant, quiet inflammatory signals such as IL-6 and TNF-alpha, and, in lab dishes, poke at the same calcium channels and the same ACE enzyme that prescription blood-pressure drugs are built to block. 'Appears' and 'in lab dishes' are load-bearing words here. Much of the mechanism work lives in animals and test tubes, which is a fine place for a hypothesis to be born and a poor place for it to retire.

The paper trail, and the size of the print

The big trial did not arrive out of nowhere. A 2021 review pooled five earlier studies (325 people in total), and at 500 mg a day, olive leaf extract lowered systolic pressure by about 5.78 mmHg versus placebo, which is roughly what a committed Mediterranean diet delivers and, in one head-to-head, roughly what a low dose of the prescription drug captopril managed. An earlier controlled trial of a phenolic-rich extract had already nudged daytime pressure down in adults with borderline-high readings, and broader reviews of the general adult population keep landing in the same modest range. Then each review does the responsible thing and stamps its own confidence 'low.' The trials tend to be small, several were funded by companies that sell the extract, and diastolic pressure often refuses to budge. This is the recurring plot of olive leaf research: the direction is consistent, the confidence is polite, and anyone promising more than that is selling something (possibly olive leaf).

Where this leaves you

Olive leaf extract is not a stand-in for a prescription, and the 2025 trial is the tell: its subjects kept taking their medication and added the leaf on top. If you already take a blood-pressure drug, stacking something that also lowers pressure is a conversation to have with a clinician, not a surprise to spring on your own circulatory system. Think of it as one more brick in a wall that also holds salt, sleep, movement, body weight, and every other unglamorous entry on the list. A polite, cumulative helper is still a helper.

If you want to try the part of the olive tree that actually holds the oleuropein, the shelf here carries standardized olive leaf extract alongside broader blood-pressure support formulas, plus cardiovascular regulars like CoQ10 and magnesium. Like everything here, it is sourced fresh per order instead of aging on a shelf, so it ships a little slower and lands a little more potent. For a polyphenol whose whole value is measured in how much oleuropein survives the trip, that is the trade worth making.

This article is for education only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease, and olive leaf extract is not a substitute for prescribed blood-pressure treatment. Talk with a qualified clinician before changing anything, especially if you take medication or are pregnant or nursing.

We Spent Centuries Bottling Olive Oil and Raking the Blood-Pressure Part Into a Pile

621 people, twelve weeks, and a cuff that never clocked out

Why a leaf would lean on your arteries at all

The paper trail, and the size of the print

Where this leaves you

Sources

Leave a comment

Save 10% off your first purchase

621 people, twelve weeks, and a cuff that never clocked out

Why a leaf would lean on your arteries at all

The paper trail, and the size of the print

Where this leaves you

Sources